Body Composition Related Evaluation of Airway Tone and Hyper-rEactivity Using Oscillometry
BREATH-OSC
1 other identifier
observational
100
1 country
1
Brief Summary
This study will determine if airway resistance to airflow and pressure, measured by Oscillometry, is associated with abnormal findings on methacholine challenge testing and whether these findings are associated with body habitus,
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 3, 2026
CompletedFirst Posted
Study publicly available on registry
January 21, 2026
CompletedStudy Start
First participant enrolled
February 17, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2027
April 13, 2026
April 1, 2026
1.4 years
January 3, 2026
April 7, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Oscillometer
The oscillometer will collect an airway impedance measurement which is made up of multiple variables.
Single measurement, approximately day 1
Study Arms (1)
Subjects with dyspnea referred for methacholine challenge testing
Subjects with dyspnea being evaluated for asthma who are referred for methacholine challenge testing
Interventions
The tremoFlo C-100 Airwave Oscillometry System is intended to measure respiratory system impedance using the Forced Oscillation Technique (FOT).
Eligibility Criteria
Up to one hundred (100) human subjects will be recruited from the following University of Rochester locations: Mary Parkes Center for Asthma, Allergy, and Pulmonary Care, the Pulmonary Clinic at Strong Memorial Hospital, and The Pulmonary Clinic at Highland Hospital.
You may qualify if:
- Willingness to perform breathing test
- Must be able to speak and understand English
- Referred for Methacholine Challenge Test
You may not qualify if:
- Unable to provide consent or perform oscillometry test
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Rochester Medical Center
Rochester, New York, 14620, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
January 3, 2026
First Posted
January 21, 2026
Study Start
February 17, 2026
Primary Completion (Estimated)
July 1, 2027
Study Completion (Estimated)
November 1, 2027
Last Updated
April 13, 2026
Record last verified: 2026-04